Nephros (NEPH) Change in Accured Expenses (2010 - 2026)
Nephros (NEPH) posted Change in Accured Expenses of $311000.0 for Q2 2026, up 139.32% on a QoQ basis from -$791000.0 in Q1 2026, and up 85.12% year-over-year from $168000.0 in Q2 2025.
Powered by 
Analysis
Nephros (NEPH) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Nephros has reported Change in Accured Expenses for 17 years, with the latest figure at $311000.0 in Q2 2026.
- On a quarterly basis, Change in Accured Expenses rose 85.12% year-over-year to $311000.0 in Q2 2026; TTM through Jun 2026 was $267000.0, a 34.72% decrease from a year earlier, with the FY2025 full-year figure at $1.0 million, up 553.1% from the prior year.
- Change in Accured Expenses was $311000.0 for Q2 2026 at Nephros, up from -$791000.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $380000.0 in Q3 2025, with the low at -$791000.0 in Q1 2026.
- Average Change in Accured Expenses over 5 years is $37444.4, with a median of $93000.0 recorded in 2022.
- The sharpest annual moves came in 2025 and 2026: Change in Accured Expenses jumped 663.64% in 2025, then tumbled 825.69% in 2026.
- Over 5 years, Change in Accured Expenses stood at $24000.0 in 2022, then soared by 237.5% to $81000.0 in 2023, then surged by 201.23% to $244000.0 in 2024, then surged by 50.41% to $367000.0 in 2025, then slipped by 15.26% to $311000.0 in 2026.
- The last three Change in Accured Expenses figures came in at $311000.0 (Q2 2026), -$791000.0 (Q1 2026), and $367000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 55.00 Mn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | -531.00 Mn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 298.00 Mn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 234.00 Mn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 123.70 Mn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | -74.00 Mn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 112.90 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn | 311,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 311,000.00 |
| Mar 31, 2026 | -791,000.00 |
| Dec 31, 2025 | 367,000.00 |
| Sep 30, 2025 | 380,000.00 |
| Jun 30, 2025 | 168,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Dec 31, 2024 | 244,000.00 |
| Sep 30, 2024 | -112,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | -380,000.00 |
| Dec 31, 2023 | 81,000.00 |
| Sep 30, 2023 | 140,000.00 |
| Jun 30, 2023 | 187,000.00 |
| Mar 31, 2023 | 98,000.00 |
| Dec 31, 2022 | 24,000.00 |
| Sep 30, 2022 | 88,000.00 |
| Jun 30, 2022 | -79,000.00 |
| Mar 31, 2022 | -183,000.00 |
| Dec 31, 2021 | -128,000.00 |
| Sep 30, 2021 | 102,000.00 |